These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 32819562)

  • 1. HIV-1 Nef promotes ubiquitination and proteasomal degradation of p53 tumor suppressor protein by using E6AP.
    Ali A; Farooqui SR; Rai J; Singh J; Kumar V; Mishra R; Banerjea AC
    Biochem Biophys Res Commun; 2020 Sep; 529(4):1038-1044. PubMed ID: 32819562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Impairment via UBE3A and HIV-1 Nef Interactions Utilizing the Ubiquitin Proteasome System.
    Pyeon D; Rojas VK; Price L; Kim S; Meharvan S; Park IW
    Viruses; 2019 Nov; 11(12):. PubMed ID: 31783587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Felis catus papillomavirus type-2 E6 binds to E6AP, promotes E6AP/p53 binding and enhances p53 proteasomal degradation.
    Altamura G; Power K; Martano M; Degli Uberti B; Galiero G; De Luca G; Maiolino P; Borzacchiello G
    Sci Rep; 2018 Dec; 8(1):17529. PubMed ID: 30510267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRIM-19 disrupts E6/E6AP complex to rescue p53 and induce apoptosis in cervical cancers.
    Zhou Y; Wei Y; Zhu J; Wang Q; Bao L; Ma Y; Chen Y; Feng D; Zhang A; Sun J; Nallar SC; Shen K; Kalvakolanu DV; Xiao W; Ling B
    PLoS One; 2011; 6(7):e22065. PubMed ID: 21765936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour suppressor p53 inhibits hepatitis C virus replication by inducing E6AP-mediated proteasomal degradation of the viral core protein.
    Park JM; Yoon H; Jeong Y; Jang KL
    FEBS Lett; 2022 Oct; 596(19):2525-2537. PubMed ID: 35918185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNF12 promotes p53-dependent cell growth suppression and apoptosis by targeting MDM2 for destruction.
    Gao K; Wang C; Jin X; Xiao J; Zhang E; Yang X; Wang D; Huang H; Yu L; Zhang P
    Cancer Lett; 2016 May; 375(1):133-141. PubMed ID: 26926424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation.
    Pal P; Lochab S; Kanaujiya JK; Kapoor I; Sanyal S; Behre G; Trivedi AK
    Cell Death Dis; 2013 Apr; 4(4):e590. PubMed ID: 23598402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepwise multipolyubiquitination of p53 by the E6AP-E6 ubiquitin ligase complex.
    Masuda Y; Saeki Y; Arai N; Kawai H; Kukimoto I; Tanaka K; Masutani C
    J Biol Chem; 2019 Oct; 294(41):14860-14875. PubMed ID: 31492752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNF125 is a ubiquitin-protein ligase that promotes p53 degradation.
    Yang L; Zhou B; Li X; Lu Z; Li W; Huo X; Miao Z
    Cell Physiol Biochem; 2015; 35(1):237-45. PubMed ID: 25591766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus core protein inhibits E6AP expression via DNA methylation to escape from ubiquitin-dependent proteasomal degradation.
    Kwak J; Shim JH; Tiwari I; Jang KL
    Cancer Lett; 2016 Sep; 380(1):59-68. PubMed ID: 27317649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53 paddy wagon: COP1, Pirh2 and MDM2 are found resisting apoptosis and growth arrest.
    Corcoran CA; Huang Y; Sheikh MS
    Cancer Biol Ther; 2004 Aug; 3(8):721-5. PubMed ID: 15280670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation.
    Fu W; Ma Q; Chen L; Li P; Zhang M; Ramamoorthy S; Nawaz Z; Shimojima T; Wang H; Yang Y; Shen Z; Zhang Y; Zhang X; Nicosia SV; Zhang Y; Pledger JW; Chen J; Bai W
    J Biol Chem; 2009 May; 284(21):13987-4000. PubMed ID: 19321440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 Ubiquitination and proteasomal degradation.
    Love IM; Shi D; Grossman SR
    Methods Mol Biol; 2013; 962():63-73. PubMed ID: 23150437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide reactivates proteasome-dependent degradation of mutant p53 protein in cancer cells in part via enhanced expression of Pirh2 E3 ligase.
    Yan W; Jung YS; Zhang Y; Chen X
    PLoS One; 2014; 9(8):e103497. PubMed ID: 25116336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.
    Sparks A; Dayal S; Das J; Robertson P; Menendez S; Saville MK
    Oncogene; 2014 Sep; 33(38):4685-96. PubMed ID: 24121268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase.
    Kao WH; Beaudenon SL; Talis AL; Huibregtse JM; Howley PM
    J Virol; 2000 Jul; 74(14):6408-17. PubMed ID: 10864652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans retinoic acid downregulates HBx levels via E6-associated protein-mediated proteasomal degradation to suppress hepatitis B virus replication.
    Han J; Jang KL
    PLoS One; 2024; 19(6):e0305350. PubMed ID: 38861553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells.
    Talis AL; Huibregtse JM; Howley PM
    J Biol Chem; 1998 Mar; 273(11):6439-45. PubMed ID: 9497376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of ubiquitin (Ub) specific protease 15 (USP15) in HIV-1 replication and viral protein degradation.
    Pyeon D; Timani KA; Gulraiz F; He JJ; Park IW
    Virus Res; 2016 Sep; 223():161-9. PubMed ID: 27460547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation.
    Yang G; Gong Y; Wang Q; Wang L; Zhang X
    Oncogene; 2017 Feb; 36(8):1023-1037. PubMed ID: 27524417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.